Financial informations

Date of approval of the final consolidated financial statements for the year ending June 2021

on 2021/09/21

In its press release of August 25, 2021 relating to the publication of the provisional annual results at the end of June 2021, Ramsay Santé indicated that the final consolidated financial statements for the year ended June 2021 would be approved by the Board of Directors at its meeting on September 23, 2021.

As the finalization of these financial statements and their review by the auditors will require additional time, it is now expected that the final consolidated financial statements for the year ended June 2021 will be approved by the Board of Directors at its meeting on October 20, 2021.

ISIN code and Euronext Paris: FR0000044471

Ramsay Santé, Financial results for the third quarter ending on March 31, 2023

13.5% total revenues growth for the third quarter of this financial year, up to €1.3bn total revenues, supported by a broad-based good dynamics and recent acquisitions in the Nordics countries. Growth on a like-for-like basis of 10.2%.

Half-year results at the end of December 2022

Ramsay Santé has continued to support health systems in both France and Nordics countries despite being heavily impacted by numerous headwinds, including salary and procurement inflation, staff shortages.

The Board of Directors of Ramsay Générale de Santé renews Pascal Roché as Chief Executive Officer

The progressive transformation of Ramsay Santé undertaken by Pascal Roché and all the teams since 2011 has enabled the European leader in health and primary care to face an unprecedented health and economic crisis, to be well positioned to respond to new health challenges and to continue its development on all stages of the patient pathway, in and out of institutions.